Therefore, we speculated that BB365896, Smarca2, Calcoco1, and Tacc1, which were coexpressed with Nfkbia, Ralbp1, and Prkce in our WGCNA, might play an inflammation-modulating role during NAFLD. The gene discussed is SMARCA2; the disease is metabolic dysfunction-associated steatotic liver disease.